Woodline Partners’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.4M | Buy |
594,620
+61,486
| +12% | +$2.21M | 0.11% | 272 |
|
|
2025
Q1 | $21M | Buy |
+533,134
| New | +$21M | 0.14% | 221 |
|
|
2024
Q4 | – | Sell |
-2,565,322
| Closed | -$60M | – | 995 |
|
|
2024
Q3 | $60M | Buy |
2,565,322
+1,145,788
| +81% | +$26.8M | 0.51% | 46 |
|
|
2024
Q2 | $25.3M | Buy |
1,419,534
+14,937
| +1% | +$266K | 0.24% | 134 |
|
|
2024
Q1 | $21.4M | Sell |
1,404,597
-363,837
| -21% | -$5.53M | 0.2% | 161 |
|
|
2023
Q4 | $30.2M | Buy |
1,768,434
+1,616,295
| +1,062% | +$27.6M | 0.33% | 91 |
|
|
2023
Q3 | $1.27M | Buy |
152,139
+10,639
| +8% | +$88.9K | 0.01% | 429 |
|
|
2023
Q2 | $3.51M | Buy |
+141,500
| New | +$3.51M | 0.04% | 344 |
|
|
2023
Q1 | – | Sell |
-2,562,100
| Closed | -$30.3M | – | 773 |
|
|
2022
Q4 | $30.3M | Buy |
2,562,100
+1,627,664
| +174% | +$19.3M | 0.41% | 56 |
|
|
2022
Q3 | $5.53M | Buy |
+934,436
| New | +$5.53M | 0.08% | 273 |
|
|
2021
Q4 | – | Sell |
-106,932
| Closed | -$3.56M | – | 787 |
|
|
2021
Q3 | $3.56M | Buy |
106,932
+4,952
| +5% | +$165K | 0.06% | 305 |
|
|
2021
Q2 | $3.96M | Sell |
101,980
-824,786
| -89% | -$32M | 0.07% | 248 |
|
|
2021
Q1 | $44.7M | Buy |
926,766
+893,514
| +2,687% | +$43.1M | 0.99% | 22 |
|
|
2020
Q4 | $1.73M | Sell |
33,252
-166,623
| -83% | -$8.67M | 0.05% | 199 |
|
|
2020
Q3 | $5.35M | Sell |
199,875
-132,777
| -40% | -$3.55M | 0.18% | 125 |
|
|
2020
Q2 | $6.48M | Buy |
+332,652
| New | +$6.48M | 0.26% | 94 |
|